Orforglipron

Drug / MedicationMentioned in 1 video

An oral small molecule drug being developed by Eli Lilly that mimics GLP-1, offering potential for wider scale manufacturing and easier administration.

Videos Mentioning Orforglipron

Dave Ricks, CEO of Eli Lilly | The All-In Interview

Dave Ricks, CEO of Eli Lilly | The All-In Interview

All-In Podcast

An oral small molecule drug being developed by Eli Lilly that mimics GLP-1, offering potential for wider scale manufacturing and easier administration.